Jul 8, 2021
In this episode, Julie Rubinstein, MBA, discusses her journey into the cancer space, the importance of personalized medicine and how her father’s cancer diagnosis played a role in her career.
- Welcome to another exciting episode of Oncology Overdrive :13
- About Rubinstein :19
- The interview 1:53
- Can you tell us a little bit about your journey into this space? 2:04
- So, they were in Seattle, and you were in New York … way before this pandemic happened were you working virtually that many years ago? 11:54
- When you were first in the immunotherapy space at the beginning of your career, did you guess that it would have such a huge impact in the cancer space? 14:46
- How did your father’s cancer diagnosis influence the way you navigated your career in the oncology space? 24:26
- Discussion on the importance of personalized medicine 35:12
- Rubinstein’s one pearl 42:20
- How to reach Rubinstein 43:35
Julie Rubinstein, MBA, is the president of Adaptive Biotechnologies. She currently oversees Life Sciences Research, Clinical Diagnostics, Drug Discovery, Corporate Marketing and Business Development functions.
We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Rubinstein can be reached via email at jrubinstein@adaptivebiotech.com.
Disclosures: Jain reports she is a paid freelance writer for Lippincott. Rubinstein is the president of Adaptive Biotechnologies and has stock and other ownership interests in the company.